Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill to prevent misuse of nitrous oxide by regulating inhalation and sales.
The problem
Nitrous oxide is increasingly misused recreationally, causing public health and safety concerns including respiratory damage and addiction.
The proposal
The bill would regulate the sale, distribution, and inhalation of nitrous oxide to prevent non-medical misuse.
The impact
Businesses selling nitrous oxide, consumers, medical providers, and law enforcement would face new regulations and enforcement requirements.
Restricting nitrous oxide misuse could reduce respiratory injuries, neurological damage, and addiction rates. Medical users would still access legitimate supplies. Communities could see fewer emergency room visits related to inhalation abuse.
Clear regulations give police enforceable tools to combat substance misuse. The bill would provide legal framework for addressing a growing problem. This could reduce strain on emergency services.
Regulations can distinguish medical use from recreational misuse. Healthcare providers retain access for legitimate anesthesia and pain management. Protections ensure patient care continues uninterrupted.
Retailers and suppliers face new compliance costs and record-keeping requirements. Small businesses may struggle with regulatory overhead. Administrative burden could increase operational expenses.
Regulation is difficult when products have legitimate industrial uses. Underground markets may emerge if restrictions are too strict. Enforcement requires significant law enforcement resources.
Some view restrictions on adult consumption as government overreach. Regulations may limit legitimate uses beyond medical purposes. Privacy concerns exist around tracking and enforcement.
Without an official summary, the exact scope and penalties are unknown. Ambiguous language could create unintended consequences. Implementation details remain unclear at this stage.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.